| Factors associated with COVID-19-related death using OpenSAFELY EJ Williamson, AJ Walker, K Bhaskaran, S Bacon, C Bates, CE Morton, ... Nature 584 (7821), 430-436, 2020 | 5539 | 2020 |
| OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients OpenSAFELY Collaborative, E Williamson, AJ Walker, K Bhaskaran, ... MedRxiv, 2020.05. 06.20092999, 2020 | 642 | 2020 |
| HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform K Bhaskaran, CT Rentsch, B MacKenna, A Schultze, A Mehrkar, CJ Bates, ... The lancet HIV 8 (1), e24-e32, 2021 | 470 | 2021 |
| Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational … R Mathur, CT Rentsch, CE Morton, WJ Hulme, A Schultze, B MacKenna, ... The Lancet 397 (10286), 1711-1724, 2021 | 392 | 2021 |
| Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the … A Schultze, AJ Walker, B MacKenna, CE Morton, K Bhaskaran, JP Brown, ... The Lancet Respiratory Medicine 8 (11), 1106-1120, 2020 | 262 | 2020 |
| Case fatality risk of the SARS-CoV-2 variant of concern B. 1.1. 7 in England, 16 November to 5 February DJ Grint, K Wing, E Williamson, HI McDonald, K Bhaskaran, D Evans, ... Eurosurveillance 26 (11), 2100256, 2021 | 218 | 2021 |
| Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the … K Bhaskaran, S Bacon, SJW Evans, CJ Bates, CT Rentsch, B MacKenna, ... The Lancet Regional Health–Europe 6, 2021 | 190 | 2021 |
| Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts AYS Wong, B MacKenna, CE Morton, A Schultze, AJ Walker, K Bhaskaran, ... Annals of the rheumatic diseases 80 (7), 943-951, 2021 | 110 | 2021 |
| Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform EJ Williamson, HI McDonald, K Bhaskaran, AJ Walker, S Bacon, S Davy, ... bmj 374, 2021 | 106 | 2021 |
| Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY HJ Curtis, P Inglesby, CE Morton, B MacKenna, A Green, W Hulme, ... British Journal of General Practice 72 (714), e51-e62, 2022 | 96 | 2022 |
| Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England H Forbes, CE Morton, S Bacon, HI McDonald, C Minassian, JP Brown, ... bmj 372, 2021 | 90 | 2021 |
| Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY AJ Walker, B MacKenna, P Inglesby, L Tomlinson, CT Rentsch, HJ Curtis, ... British Journal of General Practice 71 (712), e806-e814, 2021 | 89 | 2021 |
| Severity of severe acute respiratory system coronavirus 2 (SARS-CoV-2) alpha variant (B. 1.1. 7) in England DJ Grint, K Wing, C Houlihan, HP Gibbs, SJW Evans, E Williamson, ... Clinical Infectious Diseases 75 (1), e1120-e1127, 2022 | 86 | 2022 |
| Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies: a nationwide cohort study in the OpenSAFELY platform B MacKenna, NA Kennedy, A Mehrkar, A Rowan, J Galloway, ... The Lancet Rheumatology 4 (7), e490-e506, 2022 | 84 | 2022 |
| Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY OpenSAFELY Collaborative, B MacKenna, HJ Curtis, CE Morton, ... MedRxiv, 2021.01. 25.21250356, 2021 | 64 | 2021 |
| Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus … CT Rentsch, NJ DeVito, B MacKenna, CE Morton, K Bhaskaran, JP Brown, ... The Lancet Rheumatology 3 (1), e19-e27, 2021 | 63 | 2021 |
| Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY … B Zheng, ACA Green, J Tazare, HJ Curtis, L Fisher, L Nab, A Schultze, ... bmj 379, 2022 | 62 | 2022 |
| Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration … K Bhaskaran, CT Rentsch, G Hickman, WJ Hulme, A Schultze, HJ Curtis, ... PLoS medicine 19 (1), e1003871, 2022 | 51 | 2022 |
| Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65 A Schultze, E Nightingale, D Evans, W Hulme, A Rosello, C Bates, ... The Lancet Regional Health–Europe 14, 2022 | 47 | 2022 |
| Ethnic differences in COVID-19 infection, hospitalisation, and mortality: an OpenSAFELY analysis of 17 million adults in England OpenSAFELY Collaborative, R Mathur, CT Rentsch, CE Morton, ... MedRxiv, 2020.09. 22.20198754, 2020 | 41 | 2020 |
